Found: 5
Select item for more details and to access through your institution.
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 2, p. e38, doi. 10.1111/bjh.17197
- By:
- Publication type:
- Article
Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 561, doi. 10.1111/bjh.14669
- By:
- Publication type:
- Article
A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E243, doi. 10.1002/ajh.26178
- By:
- Publication type:
- Article
Phase I/II study of high dose pomalidomide with G‐CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E232, doi. 10.1002/ajh.25858
- By:
- Publication type:
- Article
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 623, doi. 10.1002/ajh.25796
- By:
- Publication type:
- Article